Review
doi: 10.1021/cn100024g.
ACS chemical neuroscience molecule spotlight on Fanapt
Affiliations
- PMID: 22778835
- PMCID: PMC3368683
- DOI: 10.1021/cn100024g
Item in Clipboard
Review
ACS chemical neuroscience molecule spotlight on Fanapt
ACS Chem Neurosci.
.
Abstract
The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
Similar articles
-
Iloperidone (Fanapt)--another second-generation antipsychotic.Med Lett Drugs Ther. 2010 Feb 22;52(1332):13-4; quiz 17. Med Lett Drugs Ther. 2010. PMID: 20208474 No abstract available.
-
Mechanism of action of brexpiprazole: comparison with aripiprazole.CNS Spectr. 2016 Feb;21(1):1-6. doi: 10.1017/S1092852915000954. CNS Spectr. 2016. PMID: 26899451
-
Serotonin 2A receptor antagonists for treatment of schizophrenia.Expert Opin Investig Drugs. 2011 Sep;20(9):1211-23. doi: 10.1517/13543784.2011.601738. Epub 2011 Jul 8. Expert Opin Investig Drugs. 2011. PMID: 21740279 Review.
-
Prospects for pharmacotherapy of schizophrenia.Lancet. 1995 Mar 4;345(8949):557-62. doi: 10.1016/s0140-6736(95)90469-7. Lancet. 1995. PMID: 7539875 Review. No abstract available.
-
An assessment of iloperidone for the treatment of schizophrenia.Expert Opin Investig Drugs. 2000 Dec;9(12):2935-43. doi: 10.1517/13543784.9.12.2935. Expert Opin Investig Drugs. 2000. PMID: 11093363 Review.
References
-
- Vanda Pharmaceuticals Press Release, May 6, 2009.
-
- FDA Press Release, May 6, 2009.
-
- Sainati S. M.; Hubbard J. W.; Chi E.; Grasing K.; Brecher M. B. (1995) Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic. J. Clin. Pharm. 35, 713−720. - PubMed
-
- Titan Pharmaceuticals Press Release, July 28, 2008.
-
- Novartis Press Release, January 11, 2010. www.novartis.com/newsroom/media-releases/en/2010/1371914.shtml.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
